ΔNp63α confers tumor cell resistance to cisplatin through the AKT1 transcriptional regulation

Tanusree Sen, Nilkantha Sen, Mariana Brait, Shahnaz Begum, Aditi Chatterjee, Mohammad Obaidul Hoque, Edward Ratovitski, David Sidransky

Research output: Contribution to journalArticle

39 Citations (Scopus)

Abstract

Strategies to address resistance to platin drugs are greatly needed in human epithelial cancers (e.g., ovarian, head/neck, and lung) where platins are used widely and resistance occurs commonly. We found that upon ΔNp63α overexpression, AKT1 and phospho-AKT1 levels are upregulated in cancer cells. Investigations using gel-shift, chromatin immunoprecipitation and functional reporter assays implicated ΔNp63α in positive regulation of AKT1 transcription. Importantly, we found that ΔNp63α, AKT1, and phospho-AKT levels are greater in 2008CI3 CDDP-resistant ovarian cancer cells than in 2008 CDDP-sensitive cells. siRNA-mediated knockdown of ΔNp63α expression dramatically decreased AKT1 expression, whereas knockdown of either ΔNp63α or AKT1 decreased cell proliferation and increased death of ovarian and head/neck cancer cells. Conversely, enforced expression of ΔNp63α increased cancer cell proliferation and reduced apoptosis. Together, our findings define a novel ΔNp63α-dependent regulatory mechanism for AKT1 expression and its role in chemotherapeutic resistance of ovarian and head/neck cancer cells.

Original languageEnglish (US)
Pages (from-to)1167-1176
Number of pages10
JournalCancer Research
Volume71
Issue number3
DOIs
StatePublished - Feb 1 2011

Fingerprint

Cisplatin
Neoplasms
Head and Neck Neoplasms
Cell Proliferation
Chromatin Immunoprecipitation
Ovarian Neoplasms
Small Interfering RNA
Neck
Gels
Head
Apoptosis
Lung
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Sen, T., Sen, N., Brait, M., Begum, S., Chatterjee, A., Hoque, M. O., ... Sidransky, D. (2011). ΔNp63α confers tumor cell resistance to cisplatin through the AKT1 transcriptional regulation. Cancer Research, 71(3), 1167-1176. https://doi.org/10.1158/0008-5472.CAN-10-1481

ΔNp63α confers tumor cell resistance to cisplatin through the AKT1 transcriptional regulation. / Sen, Tanusree; Sen, Nilkantha; Brait, Mariana; Begum, Shahnaz; Chatterjee, Aditi; Hoque, Mohammad Obaidul; Ratovitski, Edward; Sidransky, David.

In: Cancer Research, Vol. 71, No. 3, 01.02.2011, p. 1167-1176.

Research output: Contribution to journalArticle

Sen, T, Sen, N, Brait, M, Begum, S, Chatterjee, A, Hoque, MO, Ratovitski, E & Sidransky, D 2011, 'ΔNp63α confers tumor cell resistance to cisplatin through the AKT1 transcriptional regulation', Cancer Research, vol. 71, no. 3, pp. 1167-1176. https://doi.org/10.1158/0008-5472.CAN-10-1481
Sen, Tanusree ; Sen, Nilkantha ; Brait, Mariana ; Begum, Shahnaz ; Chatterjee, Aditi ; Hoque, Mohammad Obaidul ; Ratovitski, Edward ; Sidransky, David. / ΔNp63α confers tumor cell resistance to cisplatin through the AKT1 transcriptional regulation. In: Cancer Research. 2011 ; Vol. 71, No. 3. pp. 1167-1176.
@article{c44f62298e534722a0ec3f511c938c42,
title = "ΔNp63α confers tumor cell resistance to cisplatin through the AKT1 transcriptional regulation",
abstract = "Strategies to address resistance to platin drugs are greatly needed in human epithelial cancers (e.g., ovarian, head/neck, and lung) where platins are used widely and resistance occurs commonly. We found that upon ΔNp63α overexpression, AKT1 and phospho-AKT1 levels are upregulated in cancer cells. Investigations using gel-shift, chromatin immunoprecipitation and functional reporter assays implicated ΔNp63α in positive regulation of AKT1 transcription. Importantly, we found that ΔNp63α, AKT1, and phospho-AKT levels are greater in 2008CI3 CDDP-resistant ovarian cancer cells than in 2008 CDDP-sensitive cells. siRNA-mediated knockdown of ΔNp63α expression dramatically decreased AKT1 expression, whereas knockdown of either ΔNp63α or AKT1 decreased cell proliferation and increased death of ovarian and head/neck cancer cells. Conversely, enforced expression of ΔNp63α increased cancer cell proliferation and reduced apoptosis. Together, our findings define a novel ΔNp63α-dependent regulatory mechanism for AKT1 expression and its role in chemotherapeutic resistance of ovarian and head/neck cancer cells.",
author = "Tanusree Sen and Nilkantha Sen and Mariana Brait and Shahnaz Begum and Aditi Chatterjee and Hoque, {Mohammad Obaidul} and Edward Ratovitski and David Sidransky",
year = "2011",
month = "2",
day = "1",
doi = "10.1158/0008-5472.CAN-10-1481",
language = "English (US)",
volume = "71",
pages = "1167--1176",
journal = "Cancer Research",
issn = "0008-5472",
publisher = "American Association for Cancer Research Inc.",
number = "3",

}

TY - JOUR

T1 - ΔNp63α confers tumor cell resistance to cisplatin through the AKT1 transcriptional regulation

AU - Sen, Tanusree

AU - Sen, Nilkantha

AU - Brait, Mariana

AU - Begum, Shahnaz

AU - Chatterjee, Aditi

AU - Hoque, Mohammad Obaidul

AU - Ratovitski, Edward

AU - Sidransky, David

PY - 2011/2/1

Y1 - 2011/2/1

N2 - Strategies to address resistance to platin drugs are greatly needed in human epithelial cancers (e.g., ovarian, head/neck, and lung) where platins are used widely and resistance occurs commonly. We found that upon ΔNp63α overexpression, AKT1 and phospho-AKT1 levels are upregulated in cancer cells. Investigations using gel-shift, chromatin immunoprecipitation and functional reporter assays implicated ΔNp63α in positive regulation of AKT1 transcription. Importantly, we found that ΔNp63α, AKT1, and phospho-AKT levels are greater in 2008CI3 CDDP-resistant ovarian cancer cells than in 2008 CDDP-sensitive cells. siRNA-mediated knockdown of ΔNp63α expression dramatically decreased AKT1 expression, whereas knockdown of either ΔNp63α or AKT1 decreased cell proliferation and increased death of ovarian and head/neck cancer cells. Conversely, enforced expression of ΔNp63α increased cancer cell proliferation and reduced apoptosis. Together, our findings define a novel ΔNp63α-dependent regulatory mechanism for AKT1 expression and its role in chemotherapeutic resistance of ovarian and head/neck cancer cells.

AB - Strategies to address resistance to platin drugs are greatly needed in human epithelial cancers (e.g., ovarian, head/neck, and lung) where platins are used widely and resistance occurs commonly. We found that upon ΔNp63α overexpression, AKT1 and phospho-AKT1 levels are upregulated in cancer cells. Investigations using gel-shift, chromatin immunoprecipitation and functional reporter assays implicated ΔNp63α in positive regulation of AKT1 transcription. Importantly, we found that ΔNp63α, AKT1, and phospho-AKT levels are greater in 2008CI3 CDDP-resistant ovarian cancer cells than in 2008 CDDP-sensitive cells. siRNA-mediated knockdown of ΔNp63α expression dramatically decreased AKT1 expression, whereas knockdown of either ΔNp63α or AKT1 decreased cell proliferation and increased death of ovarian and head/neck cancer cells. Conversely, enforced expression of ΔNp63α increased cancer cell proliferation and reduced apoptosis. Together, our findings define a novel ΔNp63α-dependent regulatory mechanism for AKT1 expression and its role in chemotherapeutic resistance of ovarian and head/neck cancer cells.

UR - http://www.scopus.com/inward/record.url?scp=79551524391&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79551524391&partnerID=8YFLogxK

U2 - 10.1158/0008-5472.CAN-10-1481

DO - 10.1158/0008-5472.CAN-10-1481

M3 - Article

C2 - 21266360

AN - SCOPUS:79551524391

VL - 71

SP - 1167

EP - 1176

JO - Cancer Research

JF - Cancer Research

SN - 0008-5472

IS - 3

ER -